COVID-19-associated opportunistic infections: a snapshot on the current reports Amir AbdoliShahab FalahiAzra Kenarkoohi Review Article 23 August 2021 Pages: 327 - 346
High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis Mehrdad RostamiHassan MansouritorghabehMohammad Parsa-Kondelaji Review Article 06 November 2021 Pages: 347 - 357
Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases Marta Araujo-CastroLĂa Nattero ChavezEider Pascual-Corrales Review Article 30 September 2021 Pages: 359 - 370
FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma Lianxiang LuoManshan LiHui Luo Original Article 12 September 2021 Pages: 371 - 384
miR-522 regulates cell proliferation, migration, invasion capacities and acts as a potential biomarker to predict prognosis in triple-negative breast cancer Wei WangWei ZhangJinglin Ma Original Article 14 September 2021 Pages: 385 - 392
PEAK1 promotes invasion and metastasis and confers drug resistance in breast cancer Xingang WangYan ZhengYu Wang Original Article Open access 23 September 2021 Pages: 393 - 402
Cortactin and HER2 as potential markers for dural-targeted therapy in advanced gastric cancer Jun WeiYimin WangYaguo Wang Original Article 17 September 2021 Pages: 403 - 410
Programmed cell death-ligand 1 (PD-L1)+ tumour cells and low-reacting programmed cell death 1 (PD1)+ tumour-infiltrating lymphocytes predict poor prognosis in Epstein–Barr virus+ diffuse large B-cell lymphoma Shoichi KimuraYumi OshiroMorishige Takeshita Original Article 13 September 2021 Pages: 411 - 419
Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis Chiara PellicanoGiorgia LeodoriEdoardo Rosato Original Article Open access 30 August 2021 Pages: 421 - 426
Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis Hamidreza EbrahimiyanShayan MostafaeiMahdi Mahmoudi Original Article 14 September 2021 Pages: 427 - 438
Factors associated with the antinuclear antibody (ANA) titer of systemic autoimmune rheumatic diseases in ANA-positive patients after treatment: a retrospective study Yun XiaoYiqiang LinYanli Zeng Original Article 20 September 2021 Pages: 439 - 446
Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese childhood-onset patients Ting MengChanjuan ShenXiangcheng Xiao Original Article 22 September 2021 Pages: 447 - 453
Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits Xu Yu-ZhuHuang Na-YaWang Xin Original Article 26 October 2021 Pages: 455 - 464
Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study Lennard P. L. GilissenStefan G. H. HeinenArnold Stronkhorst Original Article 20 September 2021 Pages: 465 - 476
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination Davide FirinuAndrea PerraLuchino Chessa Original Article Open access 05 November 2021 Pages: 477 - 485
Effectiveness of methylprednisolone therapy in patients with a high-risk common type of COVID-19 pneumonia: a retrospective cohort study Lei LiuHang QuLi Chun Che Original Article 22 October 2021 Pages: 487 - 497